Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Dey Pharma to Offer EpiPen 2-Pak® and EpiPen Jr 2-Pak® Exclusively

August 24, 2011 By Bio-Medicine.Org

BASKING RIDGE, N.J., Aug. 24, 2011 /PRNewswire/ — Dey Pharma,
L.P., a subsidiary of Mylan Inc. (Nasdaq:
MYL
), today announced that Dey will exclusively offer the
EpiPen 2-Pak® and EpiPen Jr 2-Pak® (epinephrine)
Auto-Injector 0.3/0.15 mg, to encourage physicians and patients to
follow recommendations by the National Institute of Allergy and
Infectious Diseases (NIAID). While there is no safety issue
with the EpiPen® and EpiPen Jr single package, Dey will
transition away from distributing and marketing these
configurations in the U.S.

The “Guidelines for the Diagnosis and Management of Food Allergy
in the United States,” which were developed by an expert panel
sponsored by the NIAID, a division of the National Institutes of
Health (NIH), recommend that patients at risk for or who have
experienced anaphylaxis have immediate access to two doses of
epinephrine.(1)  More specifically, the guidelines indicate
that if a patient responds poorly to the initial dose or has
ongoing or progressive symptoms despite initial dosing, repeated
dosing may be required after five to 15 minutes.(1)  Patients
should seek immediate emergency medical treatment after use of
EpiPen or EpiPen Jr.

Mylan President Heather Bresch commented: “Many people may not
be aware that recent food allergy guidelines state that patients at
risk for or who have experienced anaphylaxis should have immediate
access to two doses of epinephrine. The decision to exclusively
offer the EpiPen 2-Pak, which contains two single EpiPen
Auto-Injectors, aligns with these guidelines, as well as with the
2011 World Allergy Organization (WAO) anaphylaxis guidelines which
recommend that physicians consider prescribing more than one
epinephrine auto-injector.(2)  Mylan and Dey are committed to
increasing the overall awareness of being prepared for a
potentially life-threatening allergi

‘/>”/>

SOURCE

Related Articles Read More >

A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies
Biotronik
FDA approves Biotronik’s programmer for implanted cardiac rhythm management devices

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech